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Abstract: The reaction of N1-substituted-5-amino-4-cyanopyrazoles with malononitrile 
and diethylmalonate occurs with formation of 6-substituted pyrazolo[3,4-d]pyrimidines, 
and pyrazolo[3,4-b]pyridines respectively. The structures of the products and conceivable 
mechanisms are discussed. 
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INTRODUCTION 
Pyrazolopyridines, pyrazolopyrimidines and related fused heterocycles are of interest as 
potential bioactive molecules. Pyrazolo[3,4-d]pyrimidines were identified as a general 
class of adenosine receptors,[1-3] due to the similarity between their structures and purines. 
Pyrazolo[3,4-b]pyridines are also important compounds as a result of their biological 
activity and structural relationship to azaindoles. A number of pyrazolo[3,4-b]pyridines 
are potentially biologically active compounds as new inhibitors of xantine oxidase.[4,5]  
Because of this wide range of activities, we have been interested on ortho-
aminocyanopyrazoles[5,6] or their derivatives as inhibitors of xanthine oxidase.[7] For this 
purpose we started from the key intermediates 1a–d (N1-substituted-5-amino-4-
cyanopyrazoles) 1 (Scheme 1) and reacted them with malononitrile and diethylmalonate 
to obtain pyrazolo[3,4-d]pyrimidines and pyrazolo[3,4-b]pyridines respectively. 
 
RESULTS AND DISCUSSION 
With the aim of obtaining condensed pyrazolo[3,4-d]pyrimidine and pyrazolo[3,4-b] 
pyridine systems the condensation has been carried out of a substituted aminopyrazole, 
which contains a cyano group in the ortho position, with malononitrile and 
diethylmalonate.  
The 5-amino-1-substitutedpyrazole-4-carbonitriles 1, were used as starting materials, they 
contain an amino and a cyano group in adjacent positions, which is required for the 
synthesis of the condensed systems including pyridine and pyrimidine. 
It has been found that reaction of compound 1a with malononitrile in refluxing ethanol in 
the presence of triethylamine afforded a yellow crystalline solid of mp 254-256oC. It was 
expected that this reaction would give the pyrazolopyrimidine 4a or pyrazolopyridine 5a 
via the intermediate 3a. However, the micro-analytical data showed that this product has 
the molecular formula C20H16N8. Furthermore, the mass spectrum (EI) of this product 
showed a molecular ion at m/z = 368 and the IR spectrum displays an absorption at 3463 
cm-1, corresponding to NH2 stretching, and no CN absorption. The 1H NMR spectrum 
reveals two singlets for the amino groups at 5.44 and 5.88 ppm and two singlets for the 
pyrazole H-3 protons. Structure 2a was thus suggested for this product. The formation of 
compound 2a may be envisaged via initial condensation of the amino group of one 
molecule of the o-aminonitrile with the cyano group of a second molecule to give an 
intermediate amidine which then undergoes a second, but intramolecular, amine-nitrile 
condensation to give the isolated product. To confirm this hypothesis, reflux of 
compound 1a in ethanol and triethylamine afforded a product completely identical to 2a. 
A similar result had been established by Taylor and Borror in the formation of 2a 
(Scheme 1).[8] 
Compounds 1b-d were refluxed under the same reaction conditions to afford 2b-d. 
In ethanolic sodium ethoxide solution, compounds 1a and 1b reacted with malononitrile 
to afford white powders of mp 242-244oC for 4a and 296-298oC for 4b, respectively. The 
1H NMR spectrum of compound 4a revealed a methylene singlet at δ 4.17 ppm and 
pyrazole H-3 as a singlet at 8.34 ppm besides other signals attributable to an aromatic 
compound and only one NH2 group at 8.0 ppm as expected (cf. Experimental). Based on 
these data it seemed that a –CH2CN side chain is present and that the cyclization took 
place by addition of the NH2 in the pyrazole 1 to the CN of the malononitrile to form the 
amidine intermediate 3 followed by an attack of the newly formed amino group to the CN 
of 1 to afford the pyrazolopyrimidine 4 and not the pyrazolopyridine 5 as shown in 
Scheme 1. Similar cyclizations with other nitriles have been reported.[9] 
On the contrary, reaction of compounds 1a,b with diethylmalonate in ethanolic sodium 
ethoxide solution gave pyrazolopyrimidines 6a,b. The structure of compounds 6 was 
confirmed by mass and NMR spectroscopic data. The 1H NMR spectrum of compound 
6a revealed the ester group as a triplet for the CH3 protons at 1.33 ppm and a quartet for 
the CH2 protons at 4.40 ppm, besides other signals assigned to aromatics, pyrazole H-3, 
one NH2 group, and an OH signal at 12.31 ppm (Scheme 1).[10] 
In an attempt to introduce a formyl group at position 3 in pyrazole 1, aminopyrazole 1 
was reacted with Vilsmeier reagent (DMF-POCl3) at 70ºC for 3h. To the product which 
was obtained structure 8 was proposed based on the NMR data which indicate the 
presence of OH group and the pyrazole H-3, the reaction proceeding via the intermediacy 
of 7 (Scheme 2). The structure of compound 8b could be confirmed by an alternative 
synthesis, as described before, converting 1b to the amide 9, by treatment with cold 
concentrated sulfuric acid, followed by boiling compound 9, mp 202-204 ºC (Lit. mp 
204-205ºC)[11], in formamide. The product isolated was the 4-hydroxypyrazolo[3,4-
d]pyrimidine 8b, whose spectral characteristics were completely coincident with the 
sample obtained before (Scheme 2).  
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Scheme 2 
The compound 8b, 4-hydroxypyrazolopyrimidine, was easily converted to the 
corresponding 4-chloropyrazolopyrimidine, the precursor to the 4-substituted 
aminopyrazolopyrimidine, as we described recently [6]. 
EXPERIMENTAL 
 
General Procedures. Melting points were determined on a Gallenkamp melting point 
apparatus and are uncorrected. IR spectra were registered on a Perkin Elmer FTIR-1600. 
1H NMR (300 MHz) and 13C NMR (75.4 MHz) spectra were recorded on a Varian Unity 
Plus Spectrometer. Double resonance, HMQC and HMBC experiments were carried out 
for complete assignment of proton and carbon signals in the NMR spectra, whenever 
possible. High resolution mass spectra were determined on a AutoSpec E spectrometer. 
Elemental analyses were obtained on a Leco CHNS-932 instrument. Compound 9 was 
prepared by a known method.[11] 
 
General procedure for preparation of 2a-d 
 
To a solution of 5-amino-4-cyano-1-substituted pyrazole 1a-d (0.2 mol), in ethanol (20 
mL) and triethylamine (2 mL) was heated under reflux for 7 h and then concentrated 
under reduced pressure. The solid product so formed was collected by filtration, washed 
with ethanol and crystallized from EtOH-H2O. 
 
Data 
6-(5-Amino-1-phenyl-1H-pyrazol-4-yl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 
(2a): Pale yellow solid (84%), mp 254-256oC (EtOH) (Lit. [8] mp 255-257oC); (max 
(Nujol mull): 3462 and 3302 (NH2) cm-1; δH (CDCl3): 5.57 (s, 2H, NH2-C-5”), 5.89 (s, 
2H, NH2-C-4), 7.30-7.42 (m, 2H, Ar-H), 7.52 (appt, 4H, 8.1 Hz, Ar-H), 7.60-7.67 (m, 2H, 
Ar-H), 8.02 (s, 1H, H-3``), 8.11 (d, 2H, J = 8.1 Hz, Ar-H), 8.23 (s, 1H, H-3); δC (CDCl3): 
99.04 (C-4``), 103.34 (C-3a), 121.72 (C-2`, C-6´or C-2´´´, C-6´´´), 123.78 (C-2`, C-6´or 
C-2´´´, C-6´´´), 126.45 (C-4`or C-4´´´), 127.68 (C-4´´´or C-4’), 129.06 (C-3`, C-5’ or C-
3´´´, C-5´´´), 129.64 (C-3`, C-5’ or C-3´´´, C-5´´´), 132.30 (C-3``), 138.23 (C-1`or C-1´´´), 
139.12 (C-1´´´ or C-1´), 141.03 (C-3), 146.89 (C-7a), 154.19 (C-5``), 157.14 (C-4), 
160.42 (C-6). m/z(%) 368 [M+] (100). Anal. calcd. for C20H16N8 (368.39): C, 65.21; H, 
4.38; N, 30.42. Found C, 65.10; H, 4.46; N, 29.99. 
 6-(5-Amino-1-(4-chlorophenyl)-1H-pyrazol-4-yl)-1-(4-chlorophenyl)-1H-pyrazolo[3,4-d] 
pyrimidin-4-amine (2b): Pale yellow solid (72%), mp 277-278oC (EtOH-DMF); υmax 
(Nujol mull): 3463 and 3304 (NH2) cm-1; δH (DMSO-d6): 6.89 (s, 2H, NH2), 7.56-7.70 
(m, 6H, Ar-H), 7.92 (br s, 2H, NH2), 8.08 (s, 1H, H-3 or H-3”), 8.28 (s, 1H, H-3 or H-3”), 
8.30 (d, 2H, J=9.0, Ar-H). Anal. calcd. for C20H14Cl2N8 (437.28): C, 54.93; H, 3.23; N, 
25.62. Found C, 55.00; H, 3.23; N, 25.47. 
 
6-(5-Amino-1-p-tolyl-1H-pyrazol-4-yl)-1-p-tolyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 
(2c): Pale yellow solid (78%), mp 262-264oC (EtOH); υmax(Nujol mull): 3395, 3336, and 
33187 (NH2) cm-1; δH (DMSO-d6): 2.35 (3H, s, CH3), 2.36 (3H, s, CH3), 6.74 (2H, s, 
NH2-C-4), 7.33 (2H, d, J=8.1 Hz, H-3´, H5´or H-3´´´, H-5´´´), 7.34 (2H, d, J=8.1 Hz, H-
3´, H5´or H-3´´´, H-5´´´), 7.50 (2H, d, J= 8.4 Hz, H-2´, H-6´or H-2´´´, H-6´´´), 7.81 (2H, 
br s, NH2-C-5”), 7.98 (1H, s, H-3), 8.04 (2H, d, J= 8.4 Hz, H-2´, H-6´or H2´´´, H-6´´´), 
8.24 (1H, s, H-3”); δC (DMSO-d6): 20.66 (CH3), 20.61 (CH3), 98.58 (C-4``), 102.40 (C-
3a), 120.58 (C-2´, C-6´or C-2´´´, C-6´´´), 123.24 (C-2`, C-6´or C-2´´´, C-6´´´), 129.65 (C-
3`, C-5’ or C-3´´´, C-5´´´), 129.81 (C-3`, C-5’ or C-3´´´, C-5´´´), 134.05 (C-3´´), 135.12 
(C-4`or C-4´´´), 136.21 (C-4´´´ or C-4’), 136.41 (C-1`or C-1´´´), 136.90 (C-1´´´ or C-1´), 
140.05 (C-3), 147.71 (C-7a), 153.82 (C-5``), 157.98 (C-4), 160.14 (C-6). Anal. calcd. for 
C22H20N8 2½ H2O (441.45): C, 59.80; H, 4.53; N, 25.37. Found C, 59.82; H, 4.83; H, 
25.06. 
 
6-(5-Amino-1-(4-bromophenyl)-1H-pyrazol-4-yl)-1-(4-bromophenyl)-1H-pyrazolo[3,4-
d] pyrimidin-4-amine (2d): Pale yellow solid (74%), mp 284-285oC (EtOH-DMF); υmax 
(Nujol mull): 3449, 3391 and 3301 (NH2) cm-1; δH (DMSO-d6): 6.90 (2H, s, NH2), 7.33 
(2H, d, J= 9.0 Hz, Ar-H), 7.69-7.78 (4H, m, Ar-H), 7.92 (2H, br s, NH2), 8.09 (1H, s, H-3 
or H-3” ), 8.26 (2H, d, J=9.0 Hz, Ar-H), 8.28 (1H, s,  H-3” or H-3´). m/z(%) (FAB+) 525 
[M++1, 79Br, 79Br] (18), 527 [M++1, 79Br, 81Br] (32), 529 [M++1, 81Br, 81Br] (19). Anal. 
calcd. for C20H14Br2N8 (526.19): C, 45.65; H, 2.68; N, 21.30. Found C, 45.70; H, 2.75; N, 
21.05. 
 
 General procedure for preparation of 4a,b and 6a,b 
A mixture of (1) (20 mmol) and malononitrile or diethylmalonate (20 mmol) was added 
to 20 mL freshly prepared sodium ethoxide solution [prepared by adding 1.0 g sodium 
metal into absolute ethanol (20 mL)] and the mixture was refluxed for 7 h, and left to 
cool overnight. The solid product so formed was collected by filtration, washed with 
ethanol and crystallized from ethanol, unless otherwise stated. 
Data 
2-(4-Amino-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)acetonitrile (4a): Pale yellow 
crystals (77%) mp 242-244oC (EtOH); υmax (Nujol mull): 3463 and 3296  (NH2), 2213 
(CN) cm-1; δH (DMSO-d6): 4.17 (s, 2H, CH2), 7.33 (t, 1H, J = 7.5 Hz, H-4´), 7.54 (t, 2H, 
J = 7.2 Hz, H-3´, H-5´), 8.00 (br s, 1H, NH2), 8.07 (br s, 2H, NH2), 8.10-8.25 (br s, 1H, 
NH2), 8.20 (d, 2H, J = 7.5 Hz, H-2´, H-6´), 8.34 (s, 1H, H-3); δC (DMSO-d6): 27.77 
(CH2), 100.13 (C-3a), 117.61 (CN), 120.45 (C-2`, C-6´), 124.12 (C-4´), 129.12 (C-3´, C-
5´), 134.13 (C-3), 138.86 (C-1`), 153.75 (C-7a), 158.34 (C-4), 159.67 (C-6). Anal. calcd. 
for C13H10N6 (250.26): C, 62.39; H, 4.03; N, 33.58. Found C, 62.27; H, 4.22; N, 33.63. 
 
2-[4-Amino-1-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]acetonitrile (4b): 
Yellow powder (81%) mp 296-298oC (EtOH-DMF); υmax (Nujol mull): 3469 and 3306, 
(NH2), 2218 (CN) cm-1; δH (DMSO-d6): 4.17 (s, 2H, CH2), 7.61 (d, 2H, J = 9.3 Hz, H-3´, 
H-5´), 8.04 (br s, 2H, NH2), 8.25 (d, 2H, J = 9.0 Hz, H-2´, H-6´), 8.37 (s, 1H, H-3); δC 
(DMSO-d6): 27.81 (CH2), 100.23 (C-3a), 117.63 (CN), 121.82 (C-2`, C-6´), 129.18 (C-3´, 
C-5´), 130.22 (C-4´), 134.63 (C-3), 137.75 (C-1`), 153.89 (C-7a), 158.37 (C-4), 159.90 
(C-6). m/z(%) (TOF) 284 [M+, 35Cl] (100), 286 [M+, 37Cl] (18). C13H9ClN6 (284.70): C, 
54.84; H, 3.19; N, 29.52. Found C, 54.78; H, 3.08; N, 29.42. 
 
Ethyl 4-amino-1-(phenyl)-6-hydroxy-1H-pyrazolo[3,4-b]pyridine-5-carboxylate (6a): 
White powder (89%) mp 197-199oC (EtOH); υmax (Nujol mull): 3505 and 3395 (NH2), 
3245 (br, OH), 1660 (C=O) cm-1; δH (DMSO-d6): 1.34 (t, 3H, J = 7.5 Hz, CH3), 4.38 (q, 
2H, J = 7.5 Hz, CH2), 7.31 (t, 1H, J = 7.5 Hz, H-4´), 7.51 (t, 2H, J = 7.5 Hz, H-3´), 8.06 
(d, 4H, J = 7.8 Hz, H-2´, H-6´, NH2), 8.44 (s, 1H, H-3), 12.32 (br s, 1H, OH); δC 
(DMSO-d6): 14.30 (CH3), 61.24 (CH2), 86.57 (C-5), 102.09 (C-3a), 121.01 (C-2`, C-6´), 
126.05 (C-4`), 129.05 (C-3`, C-5´), 135.12 (C-3), 138.87 (C-1`), 148.95 (C-7a), 152.76 
(C-4), 165.99 (C-6), 170.33 (C=O). Anal. calcd. for C15H14N4O3 (298.30): C, 60.40; H, 
4.73; N, 18.78. Found C, 59.99; H, 4.93; N, 18.58. 
 
Ethyl 4-amino-1-(4-chlorophenyl)-6-hydroxy-1H-pyrazolo[3,4-b]pyridine-5-carboxylate 
(6b): White powder (82%) mp 314-315oC (EtOH-DMF); υmax (Nujol mull): 3486 and 
3363 (NH2), 3179 (br, OH), 1687 (C=O) cm-1; δH (DMSO-d6): 1.32 (t, 3H, J = 7.5 Hz, 
CH3), 4.36 (q, 2H, J = 7.5 Hz, CH2), 7.55 (d, 2H, J = 7.0 Hz, Ar-H), 7.95 (s, 2H, NH2), 
8.20 (d, 2H, J = 7.0 Hz, Ar-H), 8.40 (s, 1H, H-3), 11.80-12.90 (br s, 1H, OH). m/z(%) 
(TOF) 332 [M+, 35Cl] (16), 334 [M+, 37Cl] (5). Anal. calcd. for C15H13ClN4O3 (332.74): C, 
54.14; H, 3.94; N, 16.84. Found C, 54.25; H, 4.09; N, 16.66. 
 
General procedure for preparation of 8a, b 
A mixture of (1) (20 mmol) and phosphoryl chloride (3.83 g, 25 mmol) in anhydrous 
DMF (5 mL) was heated under stirring at 70oC for 3 h. Then, the reaction mixture was 
poured onto ice and treated with aqueous ammonia (pH 8). A white solid separated and it 
was filtered off, washed with water, dried and recrystallized from an appropriate solvent 
to afford the products in 60–82% yields. 
 
1-Phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ol (8a): White powder (70%) mp 294-296oC 
(EtOH-DMF), (Lit. mp 299oC [11]) δH (DMSO-d6): 7.38 (t, 1H, J = 7.8 Hz, H-4´), 7.54 (t, 
2H, J = 7.8 Hz, H-3´and H-5´), 8.03 (d, 2H, J = 7.5 Hz, H-2´, H-6´), 8.19 (s, 1H, H-6), 
8.32 (s, 1H, H-3), 12.46 (br s, 1H, OH); δC (DMSO-d6): 107.62 (C-3a), 121.75 (C-2`, C-
6´), 127.13 (C-4`), 129.22 (C-3`, C-5´), 136.00 (C-3), 132.22 (C-1`), 148.81 (C-6), 
151.85 (C-7a), 157.23 (C-4). Anal. calcd. for C11H8N4O (212.21): C, 62.26; H, 3.80; N, 
26.40. Found C, 61.89; H, 3.87; N, 26.75. 
 
1-(4-Chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ol (8b): White powder (74%) mp 
314-316oC (EtOH-DMF), (Lit. mp >300oC [11]) δH (DMSO-d6): 7.63 (d, 2H, J = 9.3 Hz, 
Ar-H), 8.10 (d, 2H, J = 9.0 Hz, Ar-H), 8.22 (s, 1H, H-6), 8.35 (s, 1H, H-3), 12.30-12.70 
(br s, 1H, OH). Anal. calcd. for C11H7ClN4O (246.65): C, 53.56; H, 2.86; N, 22.71. 
Found C, 53.16; H, 3.04; N, 22.55. 
 
5-Amino-1-(4-chlorophenyl)-1H-pyrazole-4-carboxamide (9): White powder (81%), mp 
202-204oC (EtOH), (Lit mp 204-205oC, [11]), υmax (Nujol mull): 3471, 3337, (NH2), 
1662 (C=O) cm-1; δH (CDCl3): 6.42 (s, 2H, NH2), 6.857 (br s, 1H, NH), 7.41 (br s, 1H, 
NH), 7.54-7.57 (m, 4H, Ar-H), 7.90 (s, 1H, H-3); δC (CDCl3): 97.65 (C-4), 124.75 (C-2`, 
C-6´), 129.30 (C-3`, C-5´), 131.21 (C-4`), 137.13 (C-1`), 139.30 (C-3), 149.48 (C-5), 
166.03 (C=O). m/z(%) (TOF) 236 [M+, 35Cl] (30), 238 [M+, 37Cl] (6). Anal. calcd. for 
C10H9ClN4O (236.66): C, 50.75; H, 3.83; N, 23.67. Found C, 51.21; H, 3.91; N, 23.71. 
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